Celanese support the sustained-release drug delivery market

Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions

Celanese announces Grant Award to develop refillable drug delivery solution

Celanese to conduct research, prototype development and characterization of a refillable contraceptive technology with award from the Bill & Melinda Gates Foundation

Ovensa and Celanese to collaborate to advance precision drug delivery

Enteris BioPharma gets featured on its oral drug delivery technology

Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability

Celanese opens drug delivery feasibility lab at Florence, Kentucky site

State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides

Nanoform and Celanese explore ways to enhance drug delivery

Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.

Evonik sells Hanau pharma assets to ProChem in strategic portfolio shift

The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas

Sameer Garaye promoted to Vice President at Hetero

Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities

Maiva Pharma inaugurates advanced sterile injectables manufacturing facility in Tamil Nadu

New Shoolagiri plant strengthens Maiva’s global CDMO capabilities with advanced isolator technology, flexible production lines, and expanded capacity for complex injectable therapies

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases

The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients